Fig. 2From: The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trialCovariate-adjusted estimate (95% CI) of proportion of patients reporting symptoms between day 0 and 13 and day 3 and 13 Legend: Covariate-adjusted site-specific estimated proportions were generated from logistic regression models adjusting for treatment arm, age, sex, day 0 parasite density and day 0 fever, with all covariates set at mean/prevalence values for all trial patientsBack to article page